These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6159454)

  • 1. Spiroperidol binding in the human caudate nucleus.
    Winkler MH; Berl S; Whetsell WO; Yahr MD
    J Neural Transm Suppl; 1980; (16):45-51. PubMed ID: 6159454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble spiroperidol binding factors from bovine caudate nucleus.
    Winkler MH; Berl S
    J Neurochem; 1982 Sep; 39(3):678-82. PubMed ID: 6178802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic haloperidol on caudate 3H-spiroperidol binding in lesioned rats.
    Rosenblatt JE; Shore D; Neckers LM; Perlow MJ; Freed WJ; Wyatt RJ
    Eur J Pharmacol; 1979 Dec; 60(4):387-8. PubMed ID: 93551
    [No Abstract]   [Full Text] [Related]  

  • 4. A rapid and simple method for assaying 3H-spiroperidol binding to solubilized dopamine receptors.
    Varmuza S; Mishra RK
    Pharmacol Res Commun; 1981 Jun; 13(6):587-605. PubMed ID: 6170077
    [No Abstract]   [Full Text] [Related]  

  • 5. [3H] spiroperidol binding to brain neurotransmitter receptors.
    Withy RM; Mayer RJ; Strange PG
    FEBS Lett; 1980 Apr; 112(2):293-5. PubMed ID: 6154601
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA; Mahler HR
    J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract]   [Full Text] [Related]  

  • 7. Solubilization and characterization of 3H-spiroperidol binding sites of calf caudate.
    Lerner MH; Rosengarten H; Friedhoff AJ
    Life Sci; 1981 Dec; 29(23):2367-74. PubMed ID: 6172690
    [No Abstract]   [Full Text] [Related]  

  • 8. 3H]Spiroperidol binding in bovine caudate nucleus [proceedings.
    Withy RM; Mayer RJ; Strange PG
    Biochem Soc Trans; 1980 Apr; 8(2):181-2. PubMed ID: 6245974
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
    Quik M; Spokes EG; Mackay AV; Bannister R
    J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of typical and atypical neuroleptics on binding of [3H]spiroperidol in calf caudate.
    Lin CW; Maayani S; Wilk S
    J Pharmacol Exp Ther; 1980 Mar; 212(3):462-8. PubMed ID: 6102144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]spiperone binding in the nigrostriatal system in human brain.
    Ruberg M; Bokobza B; Javoy-Agid F; Montfort JC; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):159-65. PubMed ID: 6203765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
    Thal LJ; Makman MH; Ahn HS; Mishra RK; Horowitz SG; Dvorkin B; Katzman R
    Life Sci; 1978 Aug; 23(6):629-33. PubMed ID: 99609
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ; Iversen LL
    J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
    Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
    Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of chronic phencyclidine or d-amphetamine treatment on [3H]spiroperidol binding in rat caudate-putamen and nucleus accumbens.
    Daiguji M; Meltzer HY
    Eur J Pharmacol; 1982 Dec; 85(3-4):339-42. PubMed ID: 7151875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
    Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain.
    Pedigo NW; Reisine TD; Fields JZ; Yamamura HI
    Eur J Pharmacol; 1978 Aug; 50(4):451-3. PubMed ID: 699968
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and partial purification of a hydrophobic protein component associated with [3H]spiroperidol-binding activity.
    Boyan-Salyers BD; Clement-Cormier Y
    Biochim Biophys Acta; 1980 Feb; 617(2):274-81. PubMed ID: 7357020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]Spiroperidol binding in normal and denervated carotid bodies.
    Dinger B; Gonzalez C; Yoshizaki K; Fidone S
    Neurosci Lett; 1981 Jan; 21(1):51-5. PubMed ID: 6163114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain.
    Klemm N; Murrin LC; Kuhar MJ
    Brain Res; 1979 Jun; 169(1):1-9. PubMed ID: 455088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.